Circulating microRNA profiling identifies microRNAs linked to prediabetes associated with alcohol dependence syndrome

MicroRNAs are abundant in serum and have emerged as important regulators of gene expression, implicating them in a wide range of diseases. The purpose of this study was to discover and validate serum miRNAs in prediabetes associated with alcohol dependence syndrome (ADS). Serum samples from ADS pati...

Full description

Saved in:
Bibliographic Details
Published inAlcohol (Fayetteville, N.Y.) Vol. 122; pp. 101 - 109
Main Authors Ramaswamy, Palaniswamy, S V, Athira, Misra, Pratibha, Chauhan, V.S., Adhvaryu, Arka, Gupta, Anurodh, G, Ankita, M K, Sibin
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2025
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:MicroRNAs are abundant in serum and have emerged as important regulators of gene expression, implicating them in a wide range of diseases. The purpose of this study was to discover and validate serum miRNAs in prediabetes associated with alcohol dependence syndrome (ADS). Serum samples from ADS patients with or without prediabetes and normoglycemic controls were subjected to microarray. Validation of identified candidate miRNAs was performed by RT-qPCR. Additionally, GO and KEGG pathway analyses were carried out to uncover target genes anticipated to be controlled by the candidate miRNAs. Notably, 198, and 172 miRNAs were differentially expressed in ADS-patients with or without prediabetes compared to healthy controls, and 7 miRNAs in ADS-patients with prediabetes compared to ADS-normoglycemic patients, respectively. Furthermore, hsa-miR-320b and hsa-miR-3135b were differentially expressed exclusively in ADS-patients with prediabetes, and this was further validated. Interestingly, GO and KEGG pathway analysis revealed that genes predicted to be modulated by the candidates were considerably enriched in numerous diabetes-related biological processes and pathways. Our findings revealed that ADS-patients with or without prediabetes have different sets of miRNAs compared to normoglycemic healthy subjects. We propose serum hsa-miR-320b and hsa-miR-3135b as potential biomarkers for the diagnosis of prediabetes in ADS-patients. •A study was conducted to discover and validate serum miRNAs in prediabetes associated with alcohol dependence syndrome (ADS), using microarray profiling and RT qPCR validation.•Seven miRNAs were differentially expressed in serum samples of ADS patients with prediabetes compared to normoglycemic ADS patients.•Hsa-miR-320b and hsa-miR-3135b were differentially expressed exclusively in ADS patients with prediabetes and this was consistent in the validation study.•GO and KEGG pathway studies revealed that genes predicted to be modulated by candidate miRNAs were involved in numerous related biological processes and pathways.•The study propose serum hsa-miR-320b and hsa-miR-3135b as potential biomarkers for the diagnosis of prediabetes associated with ADS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0741-8329
1873-6823
1873-6823
DOI:10.1016/j.alcohol.2024.01.003